ATTIVITA’ SCIENTIFICA
Pubblicazioni se Riviste Scientifiche Indicizzate: 818
Impact Factor: 4748.508
Numero Totale Di Citazioni: 19393
H-Index: 72
Capitoli Di Libri Internazionali: 6
PARTECIPAZIONE A STUDI CLINICI PROSPETTICI MULTI-ISTITUZIONALI
Principal Investigator dei seguenti studi clinici
- Cordinatore Nazionele e Principal Investigator per l’Italia dello sturio EORTC 30072 SORCE trial: “A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse”.
- Cordinatore Nazionele e Principal Investigator per l’Italia dello sturio EORTC 22043-30041 study “Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment vs post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0 M0/pT2 R1 N0 M0, Gleason score 5-10, prostatic carcinoma. A phase III study”.
- Principal Investigator per l’Italia dello stdio CV-9104-004 (CureVac GmbH): a Randomised, double-blind, placebo-controlled phase I/II trial of RNActive®-derived cancer vaccine (CV9104) for asymptomatic or minimally symptomatic patients with metastatic, castrate-refractory prostate cancer.
- Principal Investigator per l’Italia dello stdio MIP-1404-201 (Molecular Insight Pharmaceuticals): A Phase 2 Assessment of the Diagnostic Accuracy of 99mTc-MIP-1404 Imaging in Men with High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pelvic Lymph Node Dissection (EPLND) Compared to Histopathology.
- Principal Investigator per l’Italia dello studio PRECISION trial: A randomised controlled trial of magnetic resonance imaging-targeted biopsy compared to standard trans-rectal ultrasound guided biopsy for the diagnosis of prostate cancer in men without biopsy
Co-Investigator dei seguenti studi clinici
- Eli Lilly. Tadalafil for radical prostatectomy patients
- Sildenafil vs apomorphine comparative study
- Vardenafil in patients with ED and depression (DRIVER)
- Advanced Bionics Corporation. Erection Pacemaker in RRP patients
- Vardenafil for patients with SCI
- Vitamin 3 analogue for BPH
- Vardenafil long term reliability
- GSK Vardenafil vs tadalafil comparative study
- UK390 for premature ejaculation phase II b (open-lable)
- UK390 for premature ejaculation phase II b (placebo-controlled)
- Vardenafil vs Tadalafil – LUTETIA
- Schwarz Pharma. Fesoterodine for overactive bladder (phase 3)
- Schwarz Pharma. Fesoterodine extension study open label
- Gen-Probe. PCA3 Cystoprostatectomy study
- Medivation. Enzalutamide in castration-resistant non-metastatic Prostate Cancer
- Risk genomic classifier in high risk prostate cancer.
- A randomized controlled trial of magnetic resonance imaging-targeted biopsy compared to standard trans-rectal ultrasound guided biopsy for the diagnosis of prostate cancer in men without prior biopsy (PRECISION)
- Società Italiana di Urologia (SIU)
- Società Italiana di Andrologia (SIA)
- European Association of Urology (EAU)
- European Society for Sexual Medicine (ESSM)
- Endourological Society
- Urological Research Society (URS)
- The Association of Academic European Urologists (AAEU)
- Genito-Urinary group of the European Organization for Research and Treatment of Cancer (EORTC)
- American Association of Genito-Urinary Surgeoens (AAGUS)
- Membro del Gruppo di studio italiano per le disfunzioni sessuali femminili, Società Italiana di Andrologia (SIA, 2006).
- Membro della Commissione Clinica, “Meetings of the European Society for Sexual Medicine (ESSM)”, 2006-2008.
- Membro del Comitato Scientifico del“Sexual Rehabilitation After Treatment For Prostate Cancer” del “Third International Consultation on Sexual Dysfunctions”, International Consultation on Urological Diseases (ICUD), Parigi, 2009.
- Membro del Comitato Scientifico M.I.R.R.O.R. (Multicenter Italian report on radical prostatectomy: Outcome and Research) della fondazione L.U.N.A. (Leading Urological No profit Advanced Research) della Societò Italiana di Urologia (SIU) nel 2010.
- Responsabile del Follow-up dopo trattamento per neoplasi prostatica, Linee guida Regionali, Lombardia dal 2011.
- Membro del comitato Scientifico della Società Italiana di Urologia dal 2010
- Membro del Scientific Congress Office (SCO) della European Association of Urology (EAU), dal 2011.
- Membro della Faculty of the European School of Urology (ESU), dal 2011.
- Membro dello Young Academic Urologists Group (YAUG) della European Association of Urology (EAU) dal 2011.
- Membro del comitato scientifico del 17° ECCO-38° ESMO- 32° ESTRO European Cancer Congress, 2013.
- Membro dell’International Clinical Cancer Research Committee (CIR2C) for Grants, National Institute of Cancer (INCA), Francia, 2013-2015.
- Membro dell’Expert Review Panel for National Grants, Cancer Research UK, Ottobre 2012.
- International Reviewer, National Grants, Swiss National Science Foundation, 2012 e 2017.
- International Reviewer, German Research Foundation (DGF), 2014-2015.
- International Reviewer, Research Foundation Flanders (FWO), 2015.
- International Reviewer, Clinical Cancer Research Committee (CIR2C) for Grants, National Institute of Cancer (INCA), 2017.
- Chairman del Comitato Scientifico dell’EMPaCT group (European Multicenter Prostate Cancer Clinical and Translational Research Group), dal 2012.
- Membro dell Comitato Scientifico dell’EMUC (European Multidisciplinary Meeting on Urological Cancer), dal 2013.
- Membro del Comitato “Minimally invasive Lymphadenectomy in Minimally Invasive Surgery in Urology (MISU)”, International Consultation on Urological Diseases – European Association of Urology (ICUD-EAU), 2013-2014.
- Membro del Prostate Cancer Committee on Cytotoxic chemotherapy and targeted agents, International Consultation on Urological Diseases – European Association of Urology (ICUD-EAU), 2013-2014.
- Membro dell’International Consortium for Health Outcomes Measurement (ICHOM), Group on Standard Set for Localized Prostate Cancer, 2015.
- Membro del tavolo dell’European Association of Urology (EAU) Section of Uropathology (ESUP).
- Membro associato dell’European Association of Urology (EAU) Section of Urological Imaging (ESUI).
- Membro associato dell’European Association of Urology (EAU) Section of Oncological Urology (ESOU).
- Chairman del Prostate cancer sub-committee, European Association of Urology (EAU) Section of Oncological Urology (ESOU).
- Insegnante dell’European Urology Residents Education Programme (EUREP), 2014-18.
- Membro dello Scientific Committee, Global Congress on Prostate Cancer, 2015.
- Membro del Pasadena Consensus Panel on Robotic Assisted Radical Prostatectomy, 2015.
- Membro dell’Impact Assessment of Guidelines Implementation and Education (IMAGINE) group, European Association of Urology (EAU) guidelines, dal 2015.
- Membro dell’European Association of Urology (EAU) Guideline Office Board, dal 2015
- Membro dell’European Association of Urology (EAU) Press Committee, dal 2015.
- Ospite del The American Association of Genitourinary Surgeons (AAGUS), al Meeting del 2016.
- Membro della Scientific Committee, European Association of Urology (EAU) update on prostate cancer Meeting di Settembre 2017.
- Membro dell’European School of Oncolgy (ESO) core faculty, Surgical Oncology – Section of Genitourinary cancer
- Lancet
- Lancet Oncology
- Journal of Clinical Oncology
- Cancer
- European Urology
- European Journal of Cancer
- Clinical Cancer Research
- The Journal of Urology
- British Journal of Urology International
- Nature Clinical Practice in Urology
- International Journal of Clinical Practice
- World Journal of Urology
- The Journal of Sexual Medicine
- International Journal of Urology
- Neurourology and Urodynamics
- Prostate Cancer and Prostatic Disease
- Radiotherapy and Oncology
- International Journal of Radiation Oncology, Biology, Physics
- Archives of Medical Science
- Canadian Journal of Surgery
- Journal of Cancer Research and Clinical Oncology
- PLOS One
- Molecular Cancer Therapeutics
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal of Clinical Epidemiology
- Supportive Care in Cancer
- OncoTargets and Therapy
- Clinical Genitourinary Cancer
- Acta Oncologica
- Vincitore nel 2009 del grant del Ministero della Salute per Giovani Ricercatori nell’ambito del tumore della prostata per il progetto intitolato: “Assessment of individual genetic profile in young individuals with and without family history of prostate cancer: implications for individualized prostate cancer screening programs” (GR-2009-10608159), (Euro: 189.000).
- Vincitore nel 2011 del grant dell’ESSM (European Society for Sexual Medicine) per la ricerca medica con il progetto intitolato: “Potential neuroprotective effects of a cannabinoid 2 receptor agonist in a rat model of cavernous nerve crush injury” (Euro: 50.000).
- Vincitore del grant per la ricerca, Sandoz Biopharmaceuticals, con il progetto intitolato: Mechanisms of resistance to anti-androgen therapies in prostate cancer (Euro: 20.000), 2015.
- Vincitore del grant per la ricerca, Sandoz Biopharmaceuticals, con il progetto intitolato: Role of macrophages in shaping disease progression in node-positive prostate cancer (Euros: 40.000), 2016.
- Membro del team Prostate Cancer Outcomes: Global Initiative to Compare & Reduce Variation (PCO-CRV protocol) – Movember Foundation (Euros: 75.000), 2016-2018
- Premi dell’European Society for Sexual Medicine (ESSM) per la migliore presentazione al Meeting selle difunsioni sessuali maschili (Clinical Science): “Five years follow-up of plaque incision and vein grafting for Peyronie’s disease”. Awarded during the European Society for Sexual Medicine meeting in Instanbul, 2003.
- Eletto nel Febbraio 2008 come “Reviewer of the Month” dalla rivista “European Urology”.
- Premio come miglior poster della sessione al 21° Meeting dell’European Association of Urology (EAU) (April 5th-8th 2006, Paris, France). Per il poster dal titolo: “A critical appraisal of the ability of body mass indes (BMI) to predict high grade prostate cancer (PCa)”.
- Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden). Per il poster dal titolo: “Adjuvant radiotherapy has a positive impact on cancer-specific survival of lymph node positive prostate cancer patients. Results of a matched analysis of a two-institution series with 703 lymph node positive patients”.
- Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il poster dal titolo: “Which is the optimal timing of erectile function assessment after bilateral nerve sparing radical prostatectomy? Results from a prospective analysis”.
- Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il post dal titolo: “Pelvic lymph node dissection should be omitted in low risk prostate cancer patients. Results of a matched analysis”.
- Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il poster dal titolo: “A novel nomogram predicting a positive [11c] choline positron emission tomography/computed tomography (PET/TC) scan in patients with biochemical recurrence after radical prostatectomy”.
- Premio come miglior poster della sessione al 26° Meeting dell’European Association of Urology (EAU) (March 18th-22nd, 2011, Vienna, Austria) con il poster dal titolo: “Adjuvant radiotherapy leads to superior recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results from a matched-controlled multi-institutional analysis”.
- Premio come miglior poster della sessione al 26° Meeting dell’European Association of Urology (EAU) (March 18th-22nd, 2011, Vienna, Austria) con il poster dal titolo: “Development and internal validation of nomograms predicting prostate cancer specific survival in patients with high risk disease. Results of a multi-institutional analysis”.
- Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 29th- June 3rd, 2010, San Francisco, CA, USA) con il poster dal titolo: “Predicting favourable pathological outcome in patients with clinical high risk prostate cancer. a novel nomogram based on a multi-institutional analysis”.
- Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 14th-19th, 2011, Washington DC, CA, USA) con il poster dal titolo: “Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: results of a matched-controlled multi-institutional analysis”.
- Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 14th-19th, 2011, Washington DC, CA, USA) con il poster dal titolo: “Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality?”
- Vincitore nel Marzo 2011 dell’ESUI Vision Award 2011 per il progetto intitolato: “The value of Computed Tomography in predicting prostate cancer lymph node invasion is negligible even in contemporary patients with very high risk of nodal metastases” presented during the26th Meeting of the European Association of Urology (March 18th-22th, 2011, Vienna, Austria).
- Premio per il progetto con il più alto contributo al congresso annuale della American Urological Association (AUA) (May16th-21st, 2014, Orlando, FL, USA), con il progetto intitolato: “The impact of time to biochemical recurrence on cancer specific mortality in patients with high risk prostate cancer treated with radical prostatectomy: a competing risks regression analysis”.
- Vincitore del premio Matula per il giovane Urologo (<40 anni) con il miglior curruculm scientifico, Società Italiana di Urologia (SIU), Ottobre 2015.
- Vincitore dell’European Association of Urology (EAU) Crystal Matula Award, per il giovane Urologo (<40 anni) con il miglior curruculm scientifico, European Association of Urology (EAU), Marzo 2016.
- Editor in Chief, European Urology Oncology
- Co-Editor, European Urology Focus (2015-2017)
- Member, Editorial Board, World Journal of Urology
- Member, Editorial Board, The Annals of Urology
- Member, Editorial Board, The Scientific World Journal (Urology section)
- Member, Editorial Board, European Medical Journal
- Member, International Editorial Committe, Urologic Oncology section, Archivos Espanoles de Urologia
- Member, Editorial Board, BioMed Research International
- Member, Editorial Committee, Minerva Urologica e Nefrologica
